Concepedia

Edward W. Chapin

EW

3

Publications

74

Citations

3

H-Index

1957

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Edward W. Chapin is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and metabolic syndrome.

Top concepts

Publications per year

1957–1992

3

Publications

3

Synthesis and hypoglycemic activity of substituted 8-(1-piperazinyl)imidazo[1,2-a]pyrazines

Laura C. Meurer, Richard L. Tolman, Edward W. Chapin et al. · Journal of Medicinal Chemistry · 1992 · 44 citations · Full text

, , +14

PHARMACOLOGY OF ETHYL-1-(4-AMINOPHENETHYL)-4-PHENYLISONIPECOTATE, ANILERIDINE, A NEW POTENT SYNTHETIC ANALGESIC

Peter D. Orahovats, Edward G. Lehman, Edward W. Chapin · Journal of Pharmacology and Experimental Therapeutics · 1957 · 20 citations

Effects of an α2-adrenoceptor antagonist on glucose tolerance in the genetically obese mouse ( )

R Saperstein, Edward W. Chapin, E.J. Brady et al. · Metabolism · 1990 · 10 citations

, , +12

Rows per page

1–3 of 3